Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.
Open Access
- 1 January 1986
- journal article
- Published by Elsevier
- Vol. 261 (3), 1393-1397
- https://doi.org/10.1016/s0021-9258(17)36105-7
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Calcium channel antagonists inhibit the acrosome reaction and bind to plasma membranes of sea urchin sperm.Proceedings of the National Academy of Sciences, 1985
- Calcium antagonistic effects of the radioligand (−)-desmethoxy-verapamil on cardiac and vascular smooth muscle preparationsCell Calcium, 1984
- Target size analysis and molecular properties of Ca2+ channels labelled with [3H]verapamilEuropean Journal of Biochemistry, 1984
- Are dihydropyridine binding sites voltage sensitive calcium channels?Life Sciences, 1984
- Cellular Action of Calcium Channel Blocking DrugsAnnual Review of Medicine, 1984
- [3H] verapamil binding sites in skeletal muscle tranverse tubule membranesBiochemical and Biophysical Research Communications, 1984
- 1,4‐Dihydropyridine Ca2+channel antagonists and activators: A comparison of binding characteristics with pharmacologyDrug Development Research, 1984
- [3H]verapamil binding sites in brain and skeletal muscle: Regulation by calciumEuropean Journal of Pharmacology, 1983
- Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazemThe American Journal of Cardiology, 1980
- Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth MuscleAnnual Review of Pharmacology and Toxicology, 1977